Nifty
Sensex
:
:
25330.25
82693.71
91.15 (0.36%)
313.02 (0.38%)

Pharmaceuticals & Drugs - Global

Rating :
40/99

BSE: 524735 | NSE: HIKAL

269.80
17-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  270
  •  271
  •  266
  •  267.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  230952
  •  62067571.75
  •  464.75
  •  245

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,325.42
  • 52.53
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,069.52
  • 0.52%
  • 2.68

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.85%
  • 1.60%
  • 16.75%
  • FII
  • DII
  • Others
  • 5.35%
  • 2.97%
  • 4.48%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.23
  • 1.57
  • -2.77

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.15
  • 0.34
  • 5.02

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.22
  • -7.37
  • 5.03

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.45
  • 45.99
  • 52.18

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.45
  • 3.89
  • 3.49

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.68
  • 16.15
  • 17.25

Earnings Forecasts:

(Updated: 16-09-2025)
Description
2024
2025
2026
2027
Adj EPS
7.36
7.3
12.4
17.14
P/E Ratio
36.66
36.96
21.76
15.74
Revenue
1843.5
1940.8
2173.8
EBITDA
328.4
333.4
435.6
514
Net Income
90.8
89.5
153.2
211.4
ROA
3.62
10.2
12.8
11.82
P/B Ratio
2.64
2.39
2.09
1.96
ROE
7.41
6.9
10.8
13.27
FCFF
68.8
211
173.2
233.36
FCFF Yield
1.74
5.34
4.38
5.91
Net Debt
746.7
608.6
511.2
351.9
BVPS
102.38
113.1
129.3
137.4

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
380.40
406.80
-6.49%
552.40
514.10
7.45%
447.70
447.50
0.04%
452.90
434.90
4.14%
Expenses
355.30
348.80
1.86%
429.00
419.70
2.22%
375.60
382.80
-1.88%
378.00
377.30
0.19%
EBITDA
25.10
58.00
-56.72%
123.40
94.40
30.72%
72.10
64.70
11.44%
74.90
57.60
30.03%
EBIDTM
6.60%
14.26%
22.34%
18.36%
16.10%
14.46%
16.54%
13.24%
Other Income
1.00
0.50
100.00%
0.50
0.50
0.00%
3.60
0.10
3,500.00%
0.40
1.00
-60.00%
Interest
17.10
19.80
-13.64%
17.90
15.30
16.99%
18.70
14.20
31.69%
18.80
13.10
43.51%
Depreciation
39.40
31.80
23.90%
37.70
32.30
16.72%
33.20
29.00
14.48%
31.70
28.60
10.84%
PBT
-30.40
6.90
-
68.30
47.30
44.40%
23.80
21.60
10.19%
24.80
16.90
46.75%
Tax
-8.00
1.80
-
18.10
13.40
35.07%
6.60
5.50
20.00%
6.50
4.30
51.16%
PAT
-22.40
5.10
-
50.20
33.90
48.08%
17.20
16.10
6.83%
18.30
12.60
45.24%
PATM
-5.89%
1.25%
9.09%
6.59%
3.84%
3.60%
4.04%
2.90%
EPS
-1.81
0.41
-
4.06
2.74
48.18%
1.39
1.30
6.92%
1.48
1.02
45.10%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
1,833.40
1,859.80
1,784.60
2,023.03
1,942.72
1,720.44
1,507.26
1,589.61
1,296.09
1,013.94
925.65
Net Sales Growth
1.67%
4.21%
-11.79%
4.13%
12.92%
14.14%
-5.18%
22.65%
27.83%
9.54%
 
Cost Of Goods Sold
831.80
837.30
824.70
1,107.03
996.39
908.37
776.32
853.82
698.90
508.88
464.89
Gross Profit
1,001.60
1,022.50
959.90
916.00
946.33
812.06
730.94
735.79
597.19
505.06
460.76
GP Margin
54.63%
54.98%
53.79%
45.28%
48.71%
47.20%
48.49%
46.29%
46.08%
49.81%
49.78%
Total Expenditure
1,537.90
1,531.40
1,517.60
1,765.96
1,602.16
1,397.55
1,234.11
1,291.48
1,054.35
815.48
744.81
Power & Fuel Cost
-
168.10
170.20
186.91
175.46
147.83
129.99
132.04
108.41
85.63
83.70
% Of Sales
-
9.04%
9.54%
9.24%
9.03%
8.59%
8.62%
8.31%
8.36%
8.45%
9.04%
Employee Cost
-
247.10
246.50
222.44
203.38
164.32
156.57
135.69
128.06
116.69
108.06
% Of Sales
-
13.29%
13.81%
11.00%
10.47%
9.55%
10.39%
8.54%
9.88%
11.51%
11.67%
Manufacturing Exp.
-
141.30
133.70
111.43
104.05
85.18
85.78
83.61
50.48
38.41
32.69
% Of Sales
-
7.60%
7.49%
5.51%
5.36%
4.95%
5.69%
5.26%
3.89%
3.79%
3.53%
General & Admin Exp.
-
72.30
86.90
80.23
60.89
38.68
43.05
35.77
28.33
30.77
26.86
% Of Sales
-
3.89%
4.87%
3.97%
3.13%
2.25%
2.86%
2.25%
2.19%
3.03%
2.90%
Selling & Distn. Exp.
-
38.40
29.60
30.89
40.71
31.46
20.45
23.36
22.52
18.02
17.09
% Of Sales
-
2.06%
1.66%
1.53%
2.10%
1.83%
1.36%
1.47%
1.74%
1.78%
1.85%
Miscellaneous Exp.
-
26.90
26.00
27.03
21.29
21.71
21.95
27.19
17.66
17.09
17.09
% Of Sales
-
1.45%
1.46%
1.34%
1.10%
1.26%
1.46%
1.71%
1.36%
1.69%
1.25%
EBITDA
295.50
328.40
267.00
257.07
340.56
322.89
273.15
298.13
241.74
198.46
180.84
EBITDA Margin
16.12%
17.66%
14.96%
12.71%
17.53%
18.77%
18.12%
18.75%
18.65%
19.57%
19.54%
Other Income
5.50
5.00
2.50
5.41
4.89
4.98
3.70
2.26
4.46
3.44
1.84
Interest
72.50
75.20
56.40
48.10
31.22
36.20
52.42
58.43
49.12
48.27
62.21
Depreciation
142.00
134.40
117.60
109.01
95.67
85.25
82.46
92.88
85.59
69.14
67.28
PBT
86.50
123.80
95.50
105.37
218.56
206.43
141.98
149.08
111.49
84.47
53.19
Tax
23.20
33.00
25.90
26.98
58.06
73.28
42.14
46.01
34.27
12.55
11.99
Tax Rate
26.82%
26.66%
27.12%
25.61%
26.56%
35.50%
33.29%
30.86%
30.74%
15.64%
22.54%
PAT
63.30
90.80
69.60
78.38
160.50
133.14
84.44
103.08
77.23
67.72
41.20
PAT before Minority Interest
63.30
90.80
69.60
78.38
160.50
133.14
84.44
103.08
77.23
67.72
41.20
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.45%
4.88%
3.90%
3.87%
8.26%
7.74%
5.60%
6.48%
5.96%
6.68%
4.45%
PAT Growth
-6.50%
30.46%
-11.20%
-51.17%
20.55%
57.67%
-18.08%
33.47%
14.04%
64.37%
 
EPS
5.13
7.36
5.64
6.36
13.02
10.80
6.85
8.36
6.26
5.49
3.34

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
1,262.30
1,187.70
1,133.47
1,067.98
933.40
816.50
756.21
669.38
604.98
563.78
Share Capital
24.70
24.70
24.66
24.66
24.66
24.66
24.66
16.44
16.44
16.44
Total Reserves
1,237.60
1,163.00
1,108.81
1,043.32
908.74
791.84
731.55
652.95
588.54
547.34
Non-Current Liabilities
533.10
643.00
590.46
431.90
378.99
410.16
359.42
311.82
324.23
336.88
Secured Loans
367.20
422.90
489.88
286.68
262.89
303.40
297.84
296.63
320.15
296.61
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
71.70
128.20
24.22
79.59
77.94
73.43
48.74
15.65
14.30
10.22
Current Liabilities
1,010.80
932.80
661.55
828.15
703.31
652.77
659.02
616.17
470.29
397.36
Trade Payables
304.10
278.80
313.27
249.07
229.62
201.16
160.01
164.55
130.43
127.87
Other Current Liabilities
192.10
172.80
157.49
232.09
148.61
133.28
136.11
113.94
75.93
62.03
Short Term Borrowings
263.30
288.60
173.31
272.60
251.43
257.54
301.88
277.16
230.24
171.96
Short Term Provisions
251.30
192.60
17.49
74.39
73.65
60.80
61.03
60.52
33.69
35.49
Total Liabilities
2,806.20
2,763.50
2,385.48
2,328.03
2,015.70
1,879.43
1,774.65
1,597.37
1,399.50
1,298.02
Net Block
1,364.50
1,070.60
948.31
879.46
712.55
735.22
712.96
633.59
668.33
623.18
Gross Block
2,225.20
1,802.40
1,563.59
1,387.80
1,127.49
1,064.92
960.28
788.33
737.47
1,147.23
Accumulated Depreciation
860.70
731.80
615.27
508.33
414.94
329.70
247.31
154.73
69.14
524.05
Non Current Assets
1,589.50
1,620.70
1,446.46
1,304.78
1,090.58
1,048.22
888.17
851.29
792.71
807.83
Capital Work in Progress
121.20
414.30
412.15
294.78
254.24
160.82
78.69
117.88
62.76
66.13
Non Current Investment
9.50
5.40
5.30
0.64
0.61
0.68
1.02
2.60
3.62
3.12
Long Term Loans & Adv.
92.50
129.40
75.91
128.77
116.34
145.30
85.40
91.55
37.81
85.55
Other Non Current Assets
1.80
1.00
4.78
1.13
6.83
6.21
10.11
5.67
20.20
29.86
Current Assets
1,216.70
1,142.80
939.02
1,023.25
925.12
831.22
886.48
746.08
606.79
490.19
Current Investments
0.00
0.00
0.00
10.27
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
334.50
303.70
316.74
328.98
266.70
312.46
364.23
303.05
263.58
291.11
Sundry Debtors
522.40
550.30
441.78
437.72
485.53
340.44
349.72
287.37
256.47
112.31
Cash & Bank
18.00
20.90
59.55
49.09
36.81
63.57
31.74
27.22
16.46
19.16
Other Current Assets
341.80
19.90
17.93
23.07
136.08
114.74
140.79
128.43
70.27
67.62
Short Term Loans & Adv.
324.90
248.00
103.01
174.12
123.79
104.25
132.37
113.93
59.54
57.43
Net Current Assets
205.90
210.00
277.47
195.10
221.81
178.44
227.45
129.91
136.51
92.84
Total Assets
2,806.20
2,763.50
2,385.48
2,328.03
2,015.70
1,879.44
1,774.65
1,597.37
1,399.50
1,298.02

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
280.40
186.70
315.31
293.73
229.02
284.93
185.59
138.81
163.48
185.61
PBT
123.80
95.50
105.37
218.56
206.43
141.98
149.08
111.49
80.27
53.19
Adjustment
215.10
174.90
163.13
126.27
126.99
136.17
158.81
140.35
126.88
133.68
Changes in Working Capital
-28.70
-53.40
75.61
18.70
-57.89
46.49
-89.69
-87.16
-23.93
11.35
Cash after chg. in Working capital
310.20
217.00
344.11
363.53
275.52
324.64
218.21
164.69
183.22
198.22
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-29.80
-30.30
-28.80
-69.80
-46.50
-24.31
-32.62
-25.87
-19.73
-12.61
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
-15.40
0.00
0.00
0.00
0.00
Cash From Investing Activity
-136.50
-173.70
-292.34
-284.37
-156.20
-163.80
-124.59
-110.12
-102.17
-63.91
Net Fixed Assets
-129.70
-240.96
-293.16
-300.85
-155.99
-186.77
-132.76
-105.98
413.05
-55.58
Net Investments
-4.10
-0.09
5.61
-10.30
0.07
0.34
1.58
1.02
-0.50
0.00
Others
-2.70
67.35
-4.79
26.78
-0.28
22.63
6.59
-5.16
-514.72
-8.33
Cash from Financing Activity
-143.60
-27.00
-7.68
-5.56
-96.87
-100.86
-55.40
-24.79
-63.28
-123.63
Net Cash Inflow / Outflow
0.30
-14.00
15.29
3.80
-24.05
20.27
5.59
3.90
-1.96
-1.93
Opening Cash & Equivalents
12.70
26.70
11.44
7.64
31.68
11.41
5.82
1.93
3.89
6.23
Closing Cash & Equivalent
13.00
12.70
26.73
11.44
7.64
31.68
11.41
5.82
1.93
4.29

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
102.21
96.17
91.93
86.62
75.70
66.22
61.33
54.29
49.07
37.16
ROA
3.26%
2.70%
3.33%
7.39%
6.84%
4.62%
6.11%
5.15%
5.02%
3.17%
ROE
7.41%
6.00%
7.12%
16.04%
15.22%
10.74%
14.46%
12.12%
12.74%
9.32%
ROCE
9.88%
7.82%
8.47%
15.21%
16.15%
12.44%
15.25%
12.81%
11.87%
11.92%
Fixed Asset Turnover
0.92
1.06
1.37
1.54
1.57
1.49
1.82
1.70
1.10
0.83
Receivable days
105.26
101.45
79.34
86.73
87.62
83.56
73.14
76.34
65.09
46.88
Inventory Days
62.63
63.45
58.25
55.96
61.44
81.93
76.61
79.54
97.91
118.04
Payable days
127.05
131.02
92.70
87.68
86.55
52.18
44.26
48.94
56.69
62.74
Cash Conversion Cycle
40.84
33.88
44.89
55.01
62.51
113.32
105.49
106.94
106.31
102.18
Total Debt/Equity
0.60
0.69
0.66
0.63
0.65
0.79
0.87
0.95
0.99
1.10
Interest Cover
2.65
2.69
3.19
8.00
6.70
3.41
3.55
3.27
2.66
1.85

News Update:


  • Hikal - Quarterly Results
    7th Aug 2025, 14:15 PM

    Read More
  • Hikal passes ANVISA’s GMP audit for Jigani unit
    17th Jun 2025, 10:30 AM

    The inspection, carried out by ANVISA, Brazil GMP, was for multiple API’s which occurred from April 14 to April 18, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.